John Vinh, KeyBanc Capital Markets equity research analyst, joins 'Squawk Box' to break down Qualcomm's quarterly earnings ...
KeyBanc raised the firm’s price target on Bio-Techne (TECH) to $90 from $80 and keeps an Overweight rating on the shares. Overall, fiscal Q2 ...
KeyBanc analyst Jeffrey Hammond reiterated a Buy rating on Hillenbrand (HI – Research Report) today. The company’s shares closed yesterday at ...
KeyBanc Capital Markets increased its price target for PTC Inc. (NASDAQ:PTC) shares from $205.00 to $211.00, while maintaining an Overweight rating. The adjustment follows PTC's first-quarter constant ...
Good morning, ladies and gentlemen, and welcome to Advanced Drainage Systems Third Quarter of Fiscal Year 2025 Results Conference Call. My name is Jale, and I'm your conference operator today. At this ...